Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.
about
Radiation dose effect in locally advanced non-small cell lung cancerCandidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitorsAn in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels.Matrilin-1 is an inhibitor of neovascularization.An evaluation of the anti-angiogenic effect of the Korean medicinal formula "Sa-mi-yeon-geon-tang" in vitro and in ovo.Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study.Marine-derived angiogenesis inhibitors for cancer therapy.Targeting the Fas/FasL signaling pathway in cancer therapy.Antiangiogenic and anticancer molecules in cartilage.What the shark immune system can and cannot provide for the expanding design landscape of immunotherapy.New approaches to selectively target cancer-associated matrix metalloproteinase activity.Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration.Antitumor bioactive peptides isolated from marine organisms.Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer.Bayesian survival analysis in clinical trials: What methods are used in practice?MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling.
P2860
Q26823043-EE5ADD54-B5D6-4F16-84CC-F0C3C04B9F27Q26830522-DD9282DF-F520-4A95-835A-5F57A9A54F10Q30528295-CC480801-79E4-442F-BFAE-434A09262DC2Q33619544-1964E83F-FFFE-4272-A7FA-43EA5C03A5D7Q35177173-738EBC08-BF2A-4633-8274-04F6562E1C1AQ35808418-558FF4A8-9C9D-4BED-B7CB-96D727A3DB66Q36994177-9D96BC60-2744-46BD-91D6-9A981D289B32Q37975245-C3FB3299-896C-4649-952D-5719F9FD707FQ38007565-64EF0AA9-69AD-427C-8207-E7C7D222FAF5Q38212365-DD737EEA-DF11-4060-AFFA-FA9244C95933Q38261141-1A04A98F-E17E-4DB4-81C5-0C0A31F10C24Q38558894-8DEE4E0A-83CC-41BB-95DC-B1D13D2C0D72Q38663010-7880B624-07C8-4E52-B9C4-BA3B17F6AFDCQ38682031-5886DE87-D129-4F18-83C1-29FC527EA9AAQ38978314-310D53A0-5090-4465-8067-D656D2C81ACDQ39185966-D183498B-95B2-4FE1-B225-4F204E4849C5Q54215275-62838C4C-445E-4CD6-AB34-96D26C2F1CEDQ54776077-29E837FC-1FA8-4B7C-BB9B-0ADD35A5546D
P2860
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Chemoradiotherapy with or with ...... a randomized phase III trial.
@ast
Chemoradiotherapy with or with ...... a randomized phase III trial.
@en
type
label
Chemoradiotherapy with or with ...... a randomized phase III trial.
@ast
Chemoradiotherapy with or with ...... a randomized phase III trial.
@en
prefLabel
Chemoradiotherapy with or with ...... a randomized phase III trial.
@ast
Chemoradiotherapy with or with ...... a randomized phase III trial.
@en
P2093
P2860
P356
P1476
Chemoradiotherapy with or with ...... a randomized phase III trial.
@en
P2093
Archie Bleyer
Benjamin T Esparaz
Charles Lu
J Jack Lee
Joseph Kelaghan
Michael J Fisch
Mylene T Truong
Pierre Desjardins
P2860
P304
P356
10.1093/JNCI/DJQ179
P407
P577
2010-05-26T00:00:00Z